Anagliptin Monotherapy for Six Months in Patients With Type 2 Diabetes Mellitus and Hyper-Low-Density Lipoprotein Cholesterolemia Reduces Plasma Levels of Fasting Low-Density Lipoprotein Cholesterol and Lathosterol: A Single-Arm Intervention Trial

Plasma Levels ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Intervention Trial ◽

Switching from atorvastatin to rosuvastatin lowers small, dense low-density lipoprotein cholesterol levels in Japanese hypercholesterolemic patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2015.10.013 ◽

2016 ◽

Vol 111 ◽

pp. 66-73 ◽

Cited By ~ 4

Author(s):

Yukihiro Bando ◽

Hitomi Toyama ◽

Hideo Kanehara ◽

Azusa Hisada ◽

Kazuhiro Okafuji ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Cholesterol Levels

Effects of Simvastatin and Ezetimibe in Lowering Low-Density Lipoprotein Cholesterol in Subjects with Type 1 and Type 2 Diabetes Mellitus

Metabolic Syndrome and Related Disorders ◽

10.1089/met.2014.0114 ◽

2015 ◽

Vol 13 (2) ◽

pp. 84-90 ◽

Cited By ~ 4

Author(s):

Kevin Ciriacks ◽

Gerard Coly ◽

Shanthi Krishnaswami ◽

Shailendra B. Patel ◽

Srividya Kidambi

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients ≥65 years of age (The Italian Longitudinal Study on Aging)

The American Journal of Cardiology ◽

10.1016/s0002-9149(02)02192-6 ◽

2002 ◽

Vol 89 (7) ◽

pp. 825-829 ◽

Cited By ~ 24

Author(s):

Vincenzo Solfrizzi ◽

Francesco Panza ◽

Anna Maria Colacicco ◽

Cristiano Capurso ◽

Alessia D’Introno ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Risk Factor ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Coronary Risk ◽

The effect of strawberry, Rome beauty apple, and their combination on the level of low-density lipoprotein cholesterol of Type 2 diabetes mellitus patients

National Journal of Physiology Pharmacy and Pharmacology ◽

10.5455/njppp.2020.10.10267202024102020 ◽

2020 ◽

pp. 1

Author(s):

Niken Yuliwati ◽

Budiyanti Wiboworini ◽

Vitri Widyaningsih

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Efficacy and Safety of ETC-1002, a Novel Investigational Low-Density Lipoprotein-Cholesterol–Lowering Therapy for the Treatment of Patients With Hypercholesterolemia and Type 2 Diabetes Mellitus

Arteriosclerosis Thrombosis and Vascular Biology ◽

10.1161/atvbaha.113.302677 ◽

2014 ◽

Vol 34 (3) ◽

pp. 676-683 ◽

Cited By ~ 83

Author(s):

Maria J. Gutierrez ◽

Noah L. Rosenberg ◽

Diane E. MacDougall ◽

Jeffrey C. Hanselman ◽

Janice R. Margulies ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Efficacy And Safety ◽

Lowering Therapy

Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus

Clinica Chimica Acta ◽

10.1016/j.cca.2009.05.015 ◽

2009 ◽

Vol 406 (1-2) ◽

pp. 71-74 ◽

Cited By ~ 18

Author(s):

Masumi Ai ◽

Seiko Otokozawa ◽

Ernst J. Schaefer ◽

Bela F. Asztalos ◽

Katsuyuki Nakajima ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Glycated Albumin ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Cholesterol Levels

Faculty Opinions recommendation of Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718226848.793509483 ◽

2015 ◽

Author(s):

Sergio Fazio

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Efficacy And Safety ◽

Lowering Therapy

Lack of Goal Attainment Regarding the Low-density Lipoprotein Cholesterol Level in the Management of Type 2 Diabetes Mellitus

Internal Medicine ◽

10.2169/internalmedicine.52.0599 ◽

2013 ◽

Vol 52 (21) ◽

pp. 2409-2415 ◽

Cited By ~ 2

Author(s):

Masaya Hosokawa ◽

Akihiro Hamasaki ◽

Kazuaki Nagashima ◽

Shinichi Harashima ◽

Kentaro Toyoda ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cholesterol Level ◽

Goal Attainment ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus

International Journal of General Medicine ◽

10.2147/ijgm.s65148 ◽

2014 ◽

pp. 355 ◽

Cited By ~ 5

Author(s):

Harold Bays

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Cholesterol Levels

Association of a reduction in low-density lipoprotein cholesterol with incident cardiovascular and cerebrovascular events among people with type 2 diabetes mellitus

European Journal of Preventive Cardiology ◽

10.1177/2047487313481752 ◽

2013 ◽

Vol 21 (7) ◽

pp. 855-865 ◽

Cited By ~ 5

Author(s):

Lin Li ◽

Baishali M Ambegaonkar ◽

John PD Reckless ◽

Susan Jick

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Cerebrovascular Events